Rue, Sarah,Eckelman, Brendan,Deveraux, Quinn,Nasoff, Marc
申请号：
AU2012328819
公开号：
AU2012328819B2
申请日:
2012.10.25
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
This disclosure relates to immunogens and monoclonal antibodies useful in the identification and/or treatment of cancer cells, including those of the dog. In one example, chimeric anti-canine CD20 antibodies are provided. The antibodies can be used therapeutically to treat lymphoma in dogs.
